(S)-16-Amino-10-benzyl-6,9,12,15-tetraoxo-3-oxa-5,8,11,14-tetraazahexadecanoic acid
Modify Date: 2024-01-13 22:27:37
(S)-16-Amino-10-benzyl-6,9,12,15-tetraoxo-3-oxa-5,8,11,14-tetraazahexadecanoic acid structure
|
Common Name | (S)-16-Amino-10-benzyl-6,9,12,15-tetraoxo-3-oxa-5,8,11,14-tetraazahexadecanoic acid | ||
|---|---|---|---|---|
| CAS Number | 1599440-20-6 | Molecular Weight | 423.42 | |
| Density | 1.339±0.06 g/cm3(Predicted) | Boiling Point | 971.9±65.0 °C(Predicted) | |
| Molecular Formula | C18H25N5O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of (S)-16-Amino-10-benzyl-6,9,12,15-tetraoxo-3-oxa-5,8,11,14-tetraazahexadecanoic acidGly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is an ADC Linker that can be used to synthesize Drug-Linker Conjugates for ADC. Especially for the synthesis of Deruxtecan (HY-13631E), a toxic drug-linker conjugate[1]. |
| Name | Glycinamide, glycylglycyl-L-phenylalanyl-N-[(carboxymethoxy)methyl]- |
|---|
| Description | Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is an ADC Linker that can be used to synthesize Drug-Linker Conjugates for ADC. Especially for the synthesis of Deruxtecan (HY-13631E), a toxic drug-linker conjugate[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.339±0.06 g/cm3(Predicted) |
|---|---|
| Boiling Point | 971.9±65.0 °C(Predicted) |
| Molecular Formula | C18H25N5O7 |
| Molecular Weight | 423.42 |